Knowledge Distillery

Filter the news according their assigned tags.

COVID-19 AND NEUROLOGY During the COVID-19 outbreak, frontline healthcare workers were mandated to wear personal protective equipment (PPE) while…

more...
| Randomised double-blinded placebo-controlled trial  

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

 

more...
| Cross-sectional case-control studies  

The objective of this study was to investigate the association between risk of COVID-19 in nonimmune individuals and the number of their family…

more...

COVID-19 AND NEUROLOGY Because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle…

more...
| Miscellaneous  

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report

 

more...
| Case series/case reports  

The objective of this study was to assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S…

more...

COVID-19 AND NEUROLOGY The aim of this multicenter study was to investigate and characterize the occurrence of olfactory and gustatory disorders in…

more...
| Expert opinion  

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the European Academy of Neurology…

more...
| Interventional study with open label/non-randomised methodology  

Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for…

more...

COVID-19 TREATMENT In this report, the authors describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with…

more...
| Expert opinion  

The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning

 

more...
| Interventional study with open label/non-randomised methodology  

The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19.

more...